AAAAAA

   
Results: 1-24 |
Results: 24
HEMOPHILIA-A GENE-THERAPY
Authors: CONNELLY S KALEKO M
Citation: S. Connelly et M. Kaleko, HEMOPHILIA-A GENE-THERAPY, Haemophilia, 4(4), 1998, pp. 380-388
AN IMPROVED METHOD FOR GENERATING RETROVIRAL PRODUCER CLONES FOR VECTORS LACKING A SELECTABLE MARKER GENE
Authors: PERSONS DA MEHAFFEY MG KALEKO M NIENHUIS AW VANIN EF
Citation: Da. Persons et al., AN IMPROVED METHOD FOR GENERATING RETROVIRAL PRODUCER CLONES FOR VECTORS LACKING A SELECTABLE MARKER GENE, Blood cells, molecules, & diseases, 24(9), 1998, pp. 167-182
CIRCUMVENTION OF IMMUNITY TO THE ADENOVIRUS MAJOR COAT PROTEIN HEXON
Authors: ROY S SHIRLEY PS MCCLELLAND A KALEKO M
Citation: S. Roy et al., CIRCUMVENTION OF IMMUNITY TO THE ADENOVIRUS MAJOR COAT PROTEIN HEXON, Journal of virology, 72(8), 1998, pp. 6875-6879
MULTIVALENT CATIONS AND LIGAND AFFINITY OF THE TYPE-1 INSULIN-LIKE-GROWTH-FACTOR RECEPTOR ON P(2)A(2)-LISN MUSCLE-CELLS
Authors: MCCUSKER RH KALEKO M SACKETT RL
Citation: Rh. Mccusker et al., MULTIVALENT CATIONS AND LIGAND AFFINITY OF THE TYPE-1 INSULIN-LIKE-GROWTH-FACTOR RECEPTOR ON P(2)A(2)-LISN MUSCLE-CELLS, Journal of cellular physiology, 176(2), 1998, pp. 392-401
SUSTAINED PHENOTYPIC CORRECTION OF MURINE HEMOPHILIA-A BY IN-VIVO GENE-THERAPY
Authors: CONNELLY S ANDREWS JL GALLO AM KAYDA DB QIAN JH HOYER L KADAN MJ GORZIGLIA MI TRAPNELL BC MCCLELLAND A KALEKO M
Citation: S. Connelly et al., SUSTAINED PHENOTYPIC CORRECTION OF MURINE HEMOPHILIA-A BY IN-VIVO GENE-THERAPY, Blood, 91(9), 1998, pp. 3273-3281
GENE-THERAPY FOR HEMOPHILIA-A
Authors: CONNELLY S KALEKO M
Citation: S. Connelly et M. Kaleko, GENE-THERAPY FOR HEMOPHILIA-A, Thrombosis and haemostasis, 78(1), 1997, pp. 31-36
HIGH-LEVEL TISSUE-SPECIFIC EXPRESSION OF FUNCTIONAL HUMAN FACTOR-VIIIIN MICE
Authors: CONNELLY S GARDNER JM MCCLELLAND A KALEKO M
Citation: S. Connelly et al., HIGH-LEVEL TISSUE-SPECIFIC EXPRESSION OF FUNCTIONAL HUMAN FACTOR-VIIIIN MICE, Human gene therapy, 7(2), 1996, pp. 183-195
TRANSIENT IMMUNOSUPPRESSION PERMITS SUCCESSFUL REPETITIVE INTRAVENOUSADMINISTRATION OF AN ADENOVIRUS VECTOR
Authors: SMITH TAG WHITE BD GARDNER JM KALEKO M MCCLELLAND A
Citation: Tag. Smith et al., TRANSIENT IMMUNOSUPPRESSION PERMITS SUCCESSFUL REPETITIVE INTRAVENOUSADMINISTRATION OF AN ADENOVIRUS VECTOR, Gene therapy, 3(6), 1996, pp. 496-502
GENE-THERAPY FOR HEMOPHILIA
Authors: SMITH T BRANN T WHITE B CONNELLY S ANDREWS J GALLO A KALEKO M KAYDA D SAKHUJA K MCCLELLAND A MAUSER A MOUNT J LOTHROP C TOLSTOSHEV P
Citation: T. Smith et al., GENE-THERAPY FOR HEMOPHILIA, Blood, 88(10), 1996, pp. 3929-3929
COMPLETE SHORT-TERM CORRECTION OF CANINE HEMOPHILIA-A BY IN-VIVO GENE-THERAPY
Authors: CONNELLY S MOUNT J MAUSER A GARDNER JM KALEKO M MCCLELLAND A LOTHROP CD
Citation: S. Connelly et al., COMPLETE SHORT-TERM CORRECTION OF CANINE HEMOPHILIA-A BY IN-VIVO GENE-THERAPY, Blood, 88(10), 1996, pp. 3846-3853
SUSTAINED EXPRESSION OF THERAPEUTIC LEVELS OF HUMAN FACTOR-VIII IN MICE
Authors: CONNELLY S GARDNER JM LYONS RM MCCLELLAND A KALEKO M
Citation: S. Connelly et al., SUSTAINED EXPRESSION OF THERAPEUTIC LEVELS OF HUMAN FACTOR-VIII IN MICE, Blood, 87(11), 1996, pp. 4671-4677
IN-VIVO GENE DELIVERY AND EXPRESSION OF PHYSIOLOGICAL LEVELS OF FUNCTIONAL HUMAN FACTOR-VIII IN MICE
Authors: CONNELLY S SMITH TAG DHIR G GARDNER JM MEHAFFEY MG ZARET KS MCCLELLAND A KALEKO M
Citation: S. Connelly et al., IN-VIVO GENE DELIVERY AND EXPRESSION OF PHYSIOLOGICAL LEVELS OF FUNCTIONAL HUMAN FACTOR-VIII IN MICE, Human gene therapy, 6(2), 1995, pp. 185-193
SUSTAINED EXPRESSION OF PHYSIOLOGICAL LEVELS OF FUNCTIONAL HUMAN FACTOR-VIII IN MICE
Authors: CONNELLY S GARDNER JM MCCLELLAND A KALEKO M
Citation: S. Connelly et al., SUSTAINED EXPRESSION OF PHYSIOLOGICAL LEVELS OF FUNCTIONAL HUMAN FACTOR-VIII IN MICE, Journal of cellular biochemistry, 1995, pp. 362-362
GENOMIC SEQUENCES INCREASE ADENOVIRAL VECTOR-MEDIATED FACTOR-IX EXPRESSION 1,900 FOLD AND ENABLE SUSTAINED EXPRESSION IN-VIVO
Authors: KALEKO M KAYDA D SAKHUJA K MEHAFFEY M MCCLELLAND A
Citation: M. Kaleko et al., GENOMIC SEQUENCES INCREASE ADENOVIRAL VECTOR-MEDIATED FACTOR-IX EXPRESSION 1,900 FOLD AND ENABLE SUSTAINED EXPRESSION IN-VIVO, Journal of cellular biochemistry, 1995, pp. 366-366
A CANINE MODEL FOR IN-VIVO GENE-THERAPY OF HEMOPHILIA-B
Authors: MAUSER AE WHITNEY KM GOODMAN SA KALEKO M SMITH TAG MCCLELLAND A LOTHROP CD
Citation: Ae. Mauser et al., A CANINE MODEL FOR IN-VIVO GENE-THERAPY OF HEMOPHILIA-B, Journal of cellular biochemistry, 1995, pp. 368-368
PHOSPHORYLATION AND ACTIVATION OF THE IGF-I RECEPTOR IN SRC TRANSFORMED-CELLS
Authors: PETERSON JE KALEKO M SIDDLE K WEBER MJ
Citation: Je. Peterson et al., PHOSPHORYLATION AND ACTIVATION OF THE IGF-I RECEPTOR IN SRC TRANSFORMED-CELLS, Journal of cellular biochemistry, 1995, pp. 25-25
LONG-TERM IN-VIVO EXPRESSION AND EFFECTIVE REPEAT DELIVERY OF A NOVELADENOVIRUS VECTOR CONTAINING A HUMAN FACTOR-IX MINIGENE
Authors: SMITH T WHITE B TOLSTOSHEV P KALEKO M MCCLELLAND A
Citation: T. Smith et al., LONG-TERM IN-VIVO EXPRESSION AND EFFECTIVE REPEAT DELIVERY OF A NOVELADENOVIRUS VECTOR CONTAINING A HUMAN FACTOR-IX MINIGENE, Blood, 86(10), 1995, pp. 945-945
COMPLETE CORRECTION OF CANINE HEMOPHILIA-A BY IN-VIVO GENE-THERAPY
Authors: CONNELLY S MOUNT J MAUSER A GARDNER J KALEKO M MCCLELLAND A LOTHROP CD
Citation: S. Connelly et al., COMPLETE CORRECTION OF CANINE HEMOPHILIA-A BY IN-VIVO GENE-THERAPY, Blood, 86(10), 1995, pp. 954-954
PHOSPHORYLATION AND ACTIVATION OF THE IGF-I RECEPTOR IN SRC TRANSFORMED-CELLS
Authors: PETERSON JE KALEKO M SIDDLE K WEBER MJ
Citation: Je. Peterson et al., PHOSPHORYLATION AND ACTIVATION OF THE IGF-I RECEPTOR IN SRC TRANSFORMED-CELLS, Journal of cellular biochemistry, 1994, pp. 142-142
ADENOVIRAL VECTOR-MEDIATED EXPRESSION OF THERAPEUTIC LEVELS OF HUMAN FACTOR-IX IN MICE
Authors: KALEKO M SMITH T MEHAFFEY M DAWN K SAUNDERS J YEI SP TRAPNELL B MCCLELLAND A
Citation: M. Kaleko et al., ADENOVIRAL VECTOR-MEDIATED EXPRESSION OF THERAPEUTIC LEVELS OF HUMAN FACTOR-IX IN MICE, Journal of cellular biochemistry, 1994, pp. 242-242
TYPE-1 INSULIN-LIKE GROWTH-FACTOR RECEPTOR OVEREXPRESSION PRODUCES DUAL EFFECTS ON MYOBLAST PROLIFERATION AND DIFFERENTIATION
Authors: QUINN LS STEINMETZ B MAAS A ONG L KALEKO M
Citation: Ls. Quinn et al., TYPE-1 INSULIN-LIKE GROWTH-FACTOR RECEPTOR OVEREXPRESSION PRODUCES DUAL EFFECTS ON MYOBLAST PROLIFERATION AND DIFFERENTIATION, Journal of cellular physiology, 159(3), 1994, pp. 387-398
C-PHOSPHORYLATION AND ACTIVATION OF THE IGF-I RECEPTOR IN SRC-TRANSFORMED CELLS
Authors: PETERSON JE JELINEK T KALEKO M SIDDLE K WEBER MJ
Citation: Je. Peterson et al., C-PHOSPHORYLATION AND ACTIVATION OF THE IGF-I RECEPTOR IN SRC-TRANSFORMED CELLS, The Journal of biological chemistry, 269(44), 1994, pp. 27315-27321
ADENOVIRUS-MEDIATED EXPRESSION OF THERAPEUTIC PLASMA-LEVELS OF HUMAN FACTOR-IX IN MICE
Authors: SMITH TAG MEHAFFEY MG KAYDA DB SAUNDERS JM YEI S TRAPNELL BC MCCLELLAND A KALEKO M
Citation: Tag. Smith et al., ADENOVIRUS-MEDIATED EXPRESSION OF THERAPEUTIC PLASMA-LEVELS OF HUMAN FACTOR-IX IN MICE, Nature genetics, 5(4), 1993, pp. 397-402
LIGAND-DEPENDENT INHIBITION OF MYOBLAST DIFFERENTIATION BY OVEREXPRESSION OF THE TYPE-1 INSULIN-LIKE GROWTH-FACTOR RECEPTOR
Authors: QUINN LS EHSAN M STEINMETZ B KALEKO M
Citation: Ls. Quinn et al., LIGAND-DEPENDENT INHIBITION OF MYOBLAST DIFFERENTIATION BY OVEREXPRESSION OF THE TYPE-1 INSULIN-LIKE GROWTH-FACTOR RECEPTOR, Journal of cellular physiology, 156(3), 1993, pp. 453-461
Risultati: 1-24 |